Administration of Formula 774-B, a genetic enhancement serum developed by René Dynes, was found to induce super gene activation, but its use was associated with a dose-dependent increase in aggressive behavior and unstable/uncontrolled manifestations of enhanced abilities in a subset of recipients. Consequently, the existing stock was neutralized and destroyed to prevent further adverse effects.
Pharmacokinetic analysis revealed a single dose duration of 20-40 minutes, with consistent manifestation of abilities upon initial expression. However, escalating dosages intensified enhanced abilities while concomitantly exacerbating behavioral changes and reducing ability control, with each successive dose significantly increasing the risk of adverse outcomes.